Free shipping on all orders over $ 500

Syk Spleen tyrosine kinase

Cat.No.  Name Information
M5252 PRT-060318 PRT-060318 (PRT318) is a novel selective inhibitor of the Syk tyrosine kinase, with IC50 of 4 nM.
M1767 R-406 R406 is an orally bioavailable and selective inhibitor of spleen tyrosine kinase (Syk) with the IC50 of 41nM and Ki value of 30 nM.
M49931 Sovleplenib Sovalleplenib is a potent, orally active, selective Syk inhibitor with an IC50 of 25 nM.Sovalleplenib inhibits tyrosine kinase-dependent Fcγ receptor-mediated phagocytosis by macrophages, which in turn reduces phagocytotic destruction of platelets, as well as reduces production of antiplatelet antibodies by B-cells.Sovalleplenib has antitumor activity in immune thrombocytopenia (ITP).
M20799 GS-9876 (lanraplenib) Lanraplenib (GS-9876, GS-SYK) is a potent, highly selective and orally active inhibitor of Spleen Tyrosine Kinase (SYK) with IC50 of 9.5 nM. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.
M20797 SRX3207 SRX3207 is a first-in-class, orally active Syk-PI3K inhibitor.
M14917 Fostamatinib disodium hexahydrate Fostamatinib (R788) disodium hexahydrate is the oral prodrug of the active compound R406.
M14916 R406 besylate R406 is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value.
M14915 Cerdulatinib hydrochloride Cerdulatinib hydrochloride (PRT062070) is a selective, oral active and reversible ATP-competitive inhibitor of dual SYK and JAK, with IC50s of 32 nM, 0.5 nM, 12 nM, 6 nM and 8 nM for SYK and Tyk2, JAK1, 2, 3, respectively.
M10688 TAK-659 hydrochloride TAK-659 hydrochloride is a highly selective, reversible, orally potent dual inhibitor of SYK/FLT3 that acts on SYK and FLT3 IC50 The values are 3.2 nM and 4.6 nM, respectively. TAK-659 hydrochloride induces tumor cell death without acting on non-tumor cells, with potential to study chronic lymphocytic leukemia (CLL).
M9012 R112 R112 is an ATP-competitive inhibitor of Syk kinase with an IC50 of 226 nM.
M5247 BAY 61-3606 dihydrochloride BAY-61-3606 is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM).
M2941 Piceatannol Piceatannol, a natural stilbene, is a selective Syk inhibitor and ~10-fold selectivity versus Lyn.
M2729 GS-9973 GS-9973 is an orally bioavailable, selective Syk inhibitor with IC50 of 7.7 nM.
M2063 P505-15 hydrochloride P505-15 (PRT062607) is a novel, highly selective inhibitor of Syk with IC50 value of 1-2 nM.
M1990 Fostamatinib Fostamatinib (R788) is a spleen tyrosine kinase (Syk) inhibitor with IC50 of 41 nM.
M1847 Fostamatinib disodium Fostamatinib disodium (R788, R-935788) is a potent, ATP-competitive and selective Syk (Spleen tyrosine kinase) inhibitor with IC50 of 41 nM.
M50405 Syk Kinase Peptide Substrate Syk Kinase Peptide Substrate is a Syk kinase peptide substrate.
M49937 TOP1288 TOP1288 is an SRC/Syk/p38α inhibitor for studies related to ulcerative colitis.
M49936 R343 R343 is an immunoglobulin E (IgE) as well as spleen tyrosine kinase (Syk) inhibitor for studies related to allergic asthma and non-small cell lung cancer.
M49935 R333 R333 is a JAK/SYK inhibitor that can be used in studies related to discoid lupus erythematosus (DLE).




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.